Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2022 1
2025 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5 results

Results by year

Filters applied: . Clear all
Page 1
Fixed-Duration Acalabrutinib Combinations in Untreated Chronic Lymphocytic Leukemia.
Brown JR, Seymour JF, Jurczak W, Aw A, Wach M, Illes A, Tedeschi A, Owen C, Skarbnik A, Lysak D, Eom KS, Šimkovič M, Pavlovsky MA, Kater AP, Eichhorst B, Miller K, Munugalavadla V, Yu T, de Borja M, Ghia P; AMPLIFY investigators; AMPLIFY Investigators. Brown JR, et al. N Engl J Med. 2025 Feb 20;392(8):748-762. doi: 10.1056/NEJMoa2409804. Epub 2025 Feb 5. N Engl J Med. 2025. PMID: 39976417 Clinical Trial.
Practical Guidance on the Clinical Management of Belantamab Mafodotin for Patients With Relapsed/Refractory Multiple Myeloma: Recommendations From the Middle East and North Africa Expert Panel.
Beksaç M, Sahli E, Rabea A, Saydam G, Tombak A, Alhuraiji A, Mutahar EY, Hosny M, Alhejazi A, Mattar M, Dal MS, Marashi M, Palamar M. Beksaç M, et al. Among authors: mutahar ey. Clin Lymphoma Myeloma Leuk. 2025 Oct;25(10):e779-e787.e1. doi: 10.1016/j.clml.2025.05.019. Epub 2025 May 20. Clin Lymphoma Myeloma Leuk. 2025. PMID: 40579284 Free article.
Guidelines on Management of Multiple Myeloma in the Relapsed/Refractory Setting: The Saudi Myeloma Working Group Guideline.
Alhejazi A, Alotaibi GS, Saleh ASA, Alahmadi M, Motabi I, Alsharif FZ, Alamer A, Abduljalil O, Tailor I, Marei M, Barefah AS, Aljabry M, Alhayli S, Usman B, Hanbali A, Alabdulwahab A, ElHemaidi I, Alahwal HM, Mutahar E, Alsaeed A. Alhejazi A, et al. Among authors: mutahar e. Clin Lymphoma Myeloma Leuk. 2025 Oct;25(10):e756-e765. doi: 10.1016/j.clml.2025.05.005. Epub 2025 May 8. Clin Lymphoma Myeloma Leuk. 2025. PMID: 40483258 Free article.
Definition, Diagnosis, Risk Stratification and Management of Newly Diagnosed Multiple Myeloma: The Saudi Myeloma Working Group Guidelines.
Alotaibi GS, Saleh ASA, Alhejazi A, Alahmadi M, Motabi I, Alsharif FZ, Alamer A, Abduljalil O, Tailor I, Marei M, Barefah AS, Aljabry M, Alhayli S, Usman B, Hanbali A, Alabdulwahab A, ElHemaidi I, Alahwal HM, Mutahar E, Alsaeed A. Alotaibi GS, et al. Among authors: mutahar e. Clin Lymphoma Myeloma Leuk. 2025 Jun 4:S2152-2650(25)00210-1. doi: 10.1016/j.clml.2025.06.005. Online ahead of print. Clin Lymphoma Myeloma Leuk. 2025. PMID: 40617770 Free article.